Are you a high-caliber grant strategist who thrives at the intersection of complex bioprocessing and non-dilutive capital? If you are ready to transition into a fast-paced, high-growth environment modeled after the world’s leading cell and gene therapy accelerators, this is your next move. We are looking for a technical powerhouse who understands that moving a therapy from bench to bedside requires more than just a lab, it requires the strategic orchestration of Horizon Europe, Vinnova, and EIC funding to fuel a world-class CDMO infrastructure.
As a PhD in the Life Sciences with a deep command of the ATMP and viral vector landscapes, you won’t just be writing proposals; you will be architecting the future of our portfolio. You will lead the charge in translating sophisticated GMP manufacturing and allogeneic/autologous workflows into high-precision technical narratives that command multi-million Euro/SEK wins.
Please note that Randstad is managing this recruitment process. While the final application deadline is 30th of April, selection and interviews are ongoing, so we encourage you to submit your application as soon as possible to ensure your candidacy.
...
